mesh condition

Headache
Intelligence

Headache intelligence: 17 indexed trials, 2 recruiting studies, 16 sponsors across 26 countries.

⚗
17Indexed trials
↗
2Recruiting
▦
16Sponsors
◎
26Countries

Leading sponsors

Pfizer20 recruiting
Danish Headache Center10 recruiting
Dartmouth-Hitchcock Medical Center10 recruiting
Dr. Ram Manohar Lohia Hospital11 recruiting
Impax Laboratories, LLC10 recruiting
Janssen-Ortho LLC10 recruiting
Medical College of Wisconsin10 recruiting
NYU Langone Health10 recruiting
Neuromed IRCCS10 recruiting
Novartis Pharmaceuticals10 recruiting
Seattle Children's Hospital10 recruiting
Tongji Hospital11 recruiting

Geographic activity

United States10trials
Italy3trials
Spain2trials
Germany2trials
Austria2trials
Denmark2trials
France2trials
Finland2trials
Belgium2trials
Greece2trials
Czechia2trials
Netherlands2trials

Leading interventions

AMG334 (70 mg) Pre-Filled Syringe (PFS)1trials
Current standard discharge educational intervention1trials
Dexmedetomidine1trials
Glycopyrrolate1trials
Hypoxia1trials
Internet-delivered CBT for Insomnia1trials
Internet-delivered CBT for Pain Management1trials
Internet-delivered Sleep Education1trials
Lenses containing prismatic correction1trials
Lenses not containing prismatic correction1trials
Lidocaine 1% Injectable Solution1trials
AMG3341trials

Methodology note

This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.